GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on October 25th 2023 with the purchase of 1,400 own shares at the average price of 7.
GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on October 24th 2023 with the purchase of 8,152 own shares at the average price of 7.
The company GR. SARANTIS S.A. announces, according to L.3556/2007 and the provisions of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, the following: Kyriakos Sarantis, CEO of the Group and Executive Member of the company’s BoD, proceeded on October 20th of 2023 with the purchase of 114,134 common shares in total at the average price of 7.
Sarantis Group achieved great success at the Best in Pharmacy Awards 2023, winning a total of 10 awards that highlight its dedication to excellence and innovation in the pharmaceutical industry. The Best in Pharmacy Awards 2023 were, once again, organized in Greeece by BOUSSIAS events, providing an opportunity for companies, products, marketing practices and services that stand out in the pharmacy sector to be recognized and enjoy the recognition they deserve.
GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on October 23rd 2023 with the purchase of 2,544 own shares at the average price of 7.
GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on October 19th 2023 with the purchase of 4,149 own shares at the average price of 7.
The company GR. SARANTIS S.A. announces, according to the articles 3 and 21 of the L.3556/2007 and the provisions of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, that the company Lenidi S.
GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on October 18th 2023 with the purchase of 13,000 own shares at the average price of 7.
Want to learn more about the Group?
Explore our latest news regarding our brands, our activities, our people and our sustainability actions!
SARANTIS Group
26, Amaroussiou - Halandriou Street
151 25 Maroussi, Athens, Greece
Tel: +30 210 6173000
Fax: +30 210 6197081
e-mail: group-info@sarantisgroup.com